Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries

BACKGROUND: Patients with rheumatoid arthritis (RA) have an increased risk of infection and malignancy compared with the general population. Infection risk is increased further with the use of disease-modifying antirheumatic drugs (DMARDs), whereas evidence on whether the use of biologic DMARDs incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dominique, Alyssa, Hetland, Merete Lund, Finckh, Axel, Gottenberg, Jacques-Eric, Iannone, Florenzo, Caporali, Roberto, Kou, Tzuyung Douglas, Nordstrom, Dan, Hernandez, Maria Victoria, Sánchez-Piedra, Carlos, Sánchez-Alonso, Fernando, Pavelka, Karel, Bond, T. Christopher, Simon, Teresa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259009/
https://www.ncbi.nlm.nih.gov/pubmed/37308978
http://dx.doi.org/10.1186/s13075-023-03067-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259009/
https://www.ncbi.nlm.nih.gov/pubmed/37308978
http://dx.doi.org/10.1186/s13075-023-03067-x

Ejemplares similares